These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 15652365)
21. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527 [TBL] [Abstract][Full Text] [Related]
22. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen. Nikumbh KV; Sevankar SG; Patil MP Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589 [TBL] [Abstract][Full Text] [Related]
23. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867 [TBL] [Abstract][Full Text] [Related]
24. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets. Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747 [TBL] [Abstract][Full Text] [Related]
25. Ketoprofen-loaded polymer carriers in bigel formulation: an approach to enhancing drug photostability in topical application forms. Andonova V; Peneva P; Georgiev GS; Toncheva VT; Apostolova E; Peychev Z; Dimitrova S; Katsarova M; Petrova N; Kassarova M Int J Nanomedicine; 2017; 12():6221-6238. PubMed ID: 28894363 [TBL] [Abstract][Full Text] [Related]
27. Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro-in vivo correlation. Corrigan OI; Devlin Y; Butler J Int J Pharm; 2003 Mar; 254(2):147-54. PubMed ID: 12623190 [TBL] [Abstract][Full Text] [Related]
28. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes. Baviskar DT; Amritkar AS; Chaudhari HS; Jain DK Pharmazie; 2012 Aug; 67(8):701-5. PubMed ID: 22957435 [TBL] [Abstract][Full Text] [Related]
29. Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet. Ahmed IS; Fatahalla FA Drug Dev Ind Pharm; 2007 May; 33(5):505-11. PubMed ID: 17520441 [TBL] [Abstract][Full Text] [Related]
30. Release and diffusional modeling of metronidazole lipid matrices. Ozyazici M; Gökçe EH; Ertan G Eur J Pharm Biopharm; 2006 Jul; 63(3):331-9. PubMed ID: 16621486 [TBL] [Abstract][Full Text] [Related]
31. Naproxen availability from variable-dose and weight sustained-release tablets. Amaral MH; Lobo JM; Ferreira DC Drug Dev Ind Pharm; 2001; 27(3):221-5. PubMed ID: 11291202 [TBL] [Abstract][Full Text] [Related]
32. [Application of synthetic and semisynthetic polymers (Kollidon K30 and hydroxypropylmethylcellulose) as carriers of ketoprofen in solid oral prolonged-release dosage forms]. Linka W; Kot M; Kołodziejczyk M Polim Med; 2016; 46(2):145-153. PubMed ID: 28397455 [TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action. Choi HK; Chun MK; Lee SH; Jang MH; Kim HD; Jung CS; Oh SY Int J Pharm; 2007 Aug; 341(1-2):50-7. PubMed ID: 17517483 [TBL] [Abstract][Full Text] [Related]
34. Bioavailability of a new ketoprofen formulation for once-daily oral administration. Roda A; Sabatini L; Mirasoli M; Baraldini M; Roda E Int J Pharm; 2002 Jul; 241(1):165-72. PubMed ID: 12086732 [TBL] [Abstract][Full Text] [Related]
35. Gamma scintigraphy in the analysis of ketoprofen behaviour from matrix tablets. Vueba ML; Rodrigues A; Lourenço P; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Int J Pharm; 2013 May; 448(1):298-304. PubMed ID: 23541984 [TBL] [Abstract][Full Text] [Related]
36. Application of a Biodegradable Polyesteramide Derived from L-Alanine as Novel Excipient for Controlled Release Matrix Tablets. Bonillo Martínez AD; Galán ICR; Bellver MVM AAPS PharmSciTech; 2017 Nov; 18(8):3286-3295. PubMed ID: 28589306 [TBL] [Abstract][Full Text] [Related]
37. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug. Prabaharan M; Mano JF Macromol Biosci; 2005 Oct; 5(10):965-73. PubMed ID: 16208630 [TBL] [Abstract][Full Text] [Related]
38. Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique. Ho C; Hwang GC Pharm Res; 1992 Feb; 9(2):206-10. PubMed ID: 1553343 [TBL] [Abstract][Full Text] [Related]
39. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam. Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289 [TBL] [Abstract][Full Text] [Related]
40. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling. Elkomy MH; Elmenshawe SF; Eid HM; Ali AM Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]